In the last trading session, 1.05 million Cognition Therapeutics Inc (NASDAQ:CGTX) shares changed hands as the company’s beta touched 0.77. With the company’s per share price at $0.31 changed hands at $0.01 or 3.87% during last session, the market valuation stood at $19.47M. CGTX’s last price was a discount, traded about -719.35% off its 52-week high of $2.54. The share price had its 52-week low at $0.22, which suggests the last value was 29.03% up since then.
Analysts gave the Cognition Therapeutics Inc (CGTX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CGTX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Cognition Therapeutics Inc’s EPS for the current quarter is expected to be -0.1.
Cognition Therapeutics Inc (NASDAQ:CGTX) trade information
Instantly CGTX was in green as seen at the end of in last trading. With action 1.32%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -55.23%, with the 5-day performance at 1.32% in the green. However, in the 30-day time frame, Cognition Therapeutics Inc (NASDAQ:CGTX) is 4.28% up.
Cognition Therapeutics Inc (CGTX) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.44%. The 2025 estimates are for Cognition Therapeutics Inc earnings to increase by 52.62%, but the outlook for the next 5-year period is at 32.88% per year.
Cognition Therapeutics Inc (NASDAQ:CGTX)’s Major holders
AWM INVESTMENT COMPANY, INC. holds the second largest percentage of outstanding shares, with 1.6224% or 0.65 million shares worth $1.08 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund. With 1.01 shares estimated at $0.32 million under it, the former controlled 1.63% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.32% of the shares, roughly 197.68 shares worth around $62071.0.
